Fingrass Novophar

Novophar S.A. (operating as Novophar Quimfa) is a pharmaceutical company based in Montevideo, Uruguay, that specializes in the development, production, and commercialization of pharmaceutical and nutritional products. Established in Uruguay in 2009 as an extension of the Paraguayan company Quimfa S.A., Novophar represents several international brands such as Nutricia, TRB Pharma, and Hexagon Nutrition. The company's portfolio includes a range of branded generics in therapeutic areas such as obesity (Fingrass, Nonagras), neurology (Dineurol), and cardiology (Liporva). In early 2025, Novophar entered into a strategic agreement with Celsius S.A. for the promotion and distribution of its products in the Uruguayan market.